Skip to content

In the BioHarmony Drug Report Database

Propranolol

Hemangeol, Inderal, Inderal La, Innopran Xl, Propranolol, Hemangiol (propranolol) is a small molecule pharmaceutical. Propranolol was first approved as Hemangeol on 1982-01-01. It is used to treat angina pectoris, esophageal and gastric varices, essential tremor, heart failure, and hypertension amongst others in the USA. It has been approved in Europe to treat hemangioma. The pharmaceutical is active against beta-1 adrenergic receptor, beta-2 adrenergic receptor, and beta-3 adrenergic receptor. In addition, it is known to target 5-hydroxytryptamine receptor 5A, sodium/bile acid cotransporter, and 5-hydroxytryptamine receptor 1A. Propranolol hydrochloride's patents are valid until 2028-10-16 (FDA).
Trade Name Hemangiol
Common Name Propranolol
Indication angina pectoris, esophageal and gastric varices, essential tremor, heart failure, hemangioma, hypertension, myocardial infarction, panic disorder, pheochromocytoma, supraventricular tachycardia, ventricular fibrillation, ventricular tachycardia
Drug Class Beta-blockers (propranolol type)
Propranolol
Get full access now